This series will utilize lectures, cases, and panel discussions aimed at enhancing knowledge and competence among fellows, advanced practice providers, MDs, and referring physicians specializing in advanced heart failure and transplant, cardiothoracic surgery and cardiac ICU. The evolving series will be designed with input from learners. We will cover a wide range of topics pertaining to advances in AHFTx, best practices, and examination of patient outcomes. As a result of participation in this educational activity, members of the healthcare team will increase their ability to: 1. Describe the mechanisms of action and key practical considerations for the use of GLP-1 receptor agonists (GLP-1 RAs). 2. Evaluate current clinical evidence regarding the safety and efficacy of GLP-1 RAs in patients with heart failure. 3. Discuss the potential role of GLP-1 RAs in facilitating peri-transplant weight management among heart failure patients.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Address:
- 750 Highland Ave
Pricing
CME included with membership
| Course Registration Fee | $50 |
Collected from the provider’s public pages · source
Top 6 courses
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Cardiac Anesthesia
- Cardiothoracic Surgery
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Geriatric Psychiatry
- Health Equity & Inclusion
- Hospital Medicine
- Infectious Disease
- Medical Leadership & Administration
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurological & Spinal Cord Injury Rehab
- Neurology
- Neuromuscular Medicine
- Neuropathology
- Neurosurgery
- Obstetrics & Gynecology
- Patient Safety & Quality Improvement
- Pediatric Emergency Medicine
- Pediatric Neurology
- Pediatric Rehabilitation Medicine
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Transplant Hepatology
- Trauma Surgery
- Vascular Neurology
- Vascular Surgery
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Rehabilitation
- Surgery
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 1 credit
- MOC · Up to 1 point
-
ReleasedNov 26, 2025
-
Last day to claim creditNov 26, 2026 7 weeks left
-
Clinical Care Options, LLC (dba Decera Clinical Education) Looking Beyond A1C in T2D Care: Incretin-Based Therapy for Cardiometabolic Risk Reduction
-
Learner’s Digest International (TM) Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes: Implications and Guidelines
-
Voxmedia LLC Exploring The Evidence: GLP-1 RAs in Individuals with T2D and ASCVD
-
University of Wisconsin-Madison Interprofessional Continuing Education Partnership Is It PAH, HFpEF or Both? Rethinking Pulmonary Hypertension – Farhan Raza MD, James Runo MD, Amy Chybowski NP, Elise Kreger PA
-
University of Wisconsin-Madison Interprofessional Continuing Education Partnership Left Ventricular Assist Devices (LVADs)-Past, Present, and Future – Libby Gutgesell NP, Veli Topkara, MD, and John Stulak, MD
-
University of Wisconsin-Madison Interprofessional Continuing Education Partnership Current Use of Cannabis and Risks/Benefits – Michael Chen, MD, FAAFP and Dae Kim, BS
